Form 4: Telesis Bio Inc. Director Todd Krueger Acquires Shares and Options

Director Todd Krueger acquired 8,390 restricted stock units and options to purchase 5,268 shares of Telesis Bio Inc. common stock on July 24, 2024.

Summary

• On July 24, 2024, Todd Krueger, a director of Telesis Bio Inc., acquired 8,390 restricted stock units (RSUs) and options to purchase 5,268 shares of common stock.
• The RSUs were granted at a price of $0 per share.
• The options have an exercise price of $4.10 per share and expire on July 24, 2034.
• The RSUs vest over time, with 3,512 RSUs vesting in equal annual installments and 4,878 RSUs vesting in full on January 1, 2025, contingent upon continued service.
• The options vest in equal monthly installments following the grant date, contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it simply reports a transaction. The acquisition of shares and options by a director is generally viewed as a positive sign, but it's not a strong indicator.

Positives

• The acquisition of RSUs and options by a director signals confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The acquisition of shares and options by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Telesis Bio Inc., Todd Krueger, Form 4, Director, RSU, Stock Options, Beneficial Ownership, TBIO